LRRK2 and Parkinson disease: The expression of proteins related to PD, including Tau, LRRK2, GBA and α-synuclein, demonstrates the potential of patient-derived hiPSCs to be utilised for the analysis of mechanisms underlying preferential neuronal vulnerability in PD.